- £4.05bn
- £4.02bn
- £364.32m
- 94
- 18
- 39
- 47
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 289 | 206 | 305 | 333 | 364 |
Selling / General / Administrative Expenses | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 75.6 | 70.6 | 78.8 | 91.3 | 106 |
Operating Profit | 214 | 135 | 226 | 241 | 258 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 214 | 135 | 226 | 241 | 260 |
Provision for Income Taxes | |||||
Net Income After Taxes | 173 | 110 | 183 | 196 | 199 |
Net Income Before Extraordinary Items | |||||
Net Income | 173 | 110 | 183 | 196 | 199 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 173 | 110 | 183 | 196 | 199 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.195 | 0.126 | 0.213 | 0.234 | 0.244 |
Dividends per Share |